- Bioreactor systems are essentially required for stem cell bioprocessing
-
Cha JM, Lee MY, Hong J
- KMID: 2469524
- Precis Future Med.
- 2019 Mar;3(1):19-23.
- doi: 10.23838/pfm.2018.00128
As stem cell technologies have rapidly advanced, the stem cell therapy market has been forecast to reach hundreds of millions of USD in market value within the next 5 years.... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic insomnia disorder: perspectives from structural neuroimaging
-
Joo EY
- KMID: 2469523
- Precis Future Med.
- 2019 Mar;3(1):10-18.
- doi: 10.23838/pfm.2018.00156
Chronic insomnia disorder is the most widely reported clinical condition in medicine. It has a significant impact on populations and is characterized by chronically disturbed sleep and sleep loss, non-refreshing... -
- CITED
-
- Close
- SHARE
-
- Close
- Updates on structural neuroimaging of narcolepsy with cataplexy
-
Joo EY
- KMID: 2469522
- Precis Future Med.
- 2019 Mar;3(1):1-9.
- doi: 10.23838/pfm.2018.00149
Narcolepsy is a chronic neurological disorder associated with abnormal regulation of the sleep-wake cycle, resulting in excessive daytime sleepiness, disturbed nocturnal sleep, and rapid eye movement (REM) sleep phenomena including... -
- CITED
-
- Close
- SHARE
-
- Close
- Isolated monocytosis was the flag preceding abnormalities in other parameters of complete blood counts in chronic myeloid leukemia with e1a2 (minor, P190) BCR-ABL1 chimeric transcripts
-
Yun JW, Yoon J, Kim JW, Kim SH, Jung CW, Kim HJ
- KMID: 2469526
- Precis Future Med.
- 2019 Mar;3(1):30-35.
- doi: 10.23838/pfm.2019.00023
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with the molecular hallmark of BCR-ABL1 chimeric transcripts from t(9;22)(q24;q22). In more than 95% of CML, the fusion occurs in the major... -
- CITED
-
- Close
- SHARE
-
- Close
- Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
-
Park SH, Lee J, Sohn TS, Lim DH, Kim KM, An JY, Choi MG, Lee JH, Bae JM, Kim S, Lee SJ, Kim ST, Park JO, Park YS, Lim HY, Kang WK
- KMID: 2469525
- Precis Future Med.
- 2019 Mar;3(1):24-29.
- doi: 10.23838/pfm.2018.00177
PURPOSE: The Adjuvant chemoRadioTherapy In Stomach Tumors 2 (ARTIST 2) trial was conducted to compare the efficacy between adjuvant chemotherapy regimens and chemoradiotherapy in D2-resected, node-positive, stage 2 or 3... -
- CITED
-
- Close
- SHARE
-
- Close
